
Click Therapeutics™
@click_tx
Expanding the possibilities of medicine with patient-centric digital treatments. #clicktherapeutics #digitaltherapeutics #softwareenhanceddrugs
ID: 703874077
http://www.clicktherapeutics.com 18-07-2012 22:04:52
318 Tweet
744 Followers
12 Following

Click Therapeutics is attending the American Headache Society 66th Annual Scientific Meeting on June 13! Stop by our booth to learn more on the future of migraine treatment with our digital therapeutic, CT-132, that is wrapping up Phase 3 trials. Learn more: americanheadachesociety.org/events/66th-an…


From NYSE: The founder of Click Therapeutics™ on the digital therapeutics space and the regulatory opportunity for combining medicines with apps. Full video: biotechtv.com/post/click-the…


Attending the 7th Neuropsychiatric Drug Development Summit today? Join us as Click’s CMO, Shaheen Lakhan takes the stage in “How Patient-Centric Prescription Digital Therapeutics Can Improve Clinical Outcomes” at 4:30 PM ET. See the full agenda here: neuropsychiatric-drug-development.com/whats-on/agend…


Click is honored to share that our CEO David Benshoof Klein has been named to the 2024 PharmaVoice 100 list, recognizing him as a top leader in the life-sciences industry within Tech and AI. Check out the full list of inspiring leaders: pharmavoice.com/news/pv100-pha… #PharmaVoice100


Click is headed to Berlin for the Frontiers Health Congress taking place October 17-18. Our CEO & Founder, David Benshoof Klein, will take the stage to share his insights on the future of medicine in a keynote and fireside chat. Learn more: frontiers.health/2024-agenda


In his latest article for MedCity News , our CMO Shaheen Lakhan explores how smartphones and social media contribute to a growing mental health crisis - and how the same technology that poses risks can also offer transformative health benefits. Learn more: medcitynews.com/2024/12/the-sa…


BREAKING NEWS: Dassault Systèmes and Medidata have made a strategic investment in Click Therapeutics™. 25 years ago we revolutionized clinical trials. Today, we’re expanding the boundaries of healthcare by combining cutting-edge science with the power of software to develop new, cutting-edge



Click Therapeutics Founder & CEO, David Benshoof Klein, delivered a keynote address at Medidata NEXT in London last week, where Click announced closing its Series C investment round, provided entirely by Dassault Systèmes . Read more here: clicktherapeutics.com/news/click-the…




Click will present Phase 3 data from the ReMMiD-C bridging study of CT-132 at the American Headache Society 2025 Annual Scientific Meeting on Saturday, June 21 at 9:10 AM CST. Cassandra Snipes, PhD, will present abstract IOR-05. Learn more: ahsam25.eventscribe.net/fsPopup.asp?Pr… #AHSAM




CT-132, Click’s prescription digital therapeutic for migraine prevention, was featured in NeurologyLive® with insights from Eric Baron, DO of Cleveland Clinic. He shares how this FDA-authorized, app-based treatment can complement existing therapies: neurologylive.com/view/eric-baro…


We’re heading to #BIO2025! Join Click at Booth 3678 where our team will be on-site and available for meetings to explore strategic partnerships across PDTs and Software-Enhanced Drug™ therapies. Looking to connect? Contact [email protected]
